Fibrocystic Breast Disease
"Fibrocystic Breast Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A common and benign breast disease characterized by varying degree of fibrocystic changes in the breast tissue. There are three major patterns of morphological changes, including FIBROSIS, formation of CYSTS, and proliferation of glandular tissue (adenosis). The fibrocystic breast has a dense irregular, lumpy, bumpy consistency.
|Fibrocystic Breast Disease
- Fibrocystic Breast Disease
- Breast Disease, Fibrocystic
- Disease, Fibrocystic Breast
- Mammary Dysplasia
- Dysplasia, Mammary
- Fibrocystic Disease of Breast
- Breast Fibrocystic Disease
- Fibrocystic Mastopathy
- Mastopathy, Fibrocystic
- Breast Dysplasia
- Dysplasia, Breast
- Fibrocystic Changes of Breast
- Breast Fibrocystic Change
- Breast Fibrocystic Changes
- Microglandular Adenosis
- Adenoses, Microglandular
- Adenosis, Microglandular
- Microglandular Adenoses
- Adenosis of Breast
- Breast Adenosis
Cystic Breast Disease
- Cystic Breast Disease
- Breast Disease, Cystic
- Disease, Cystic Breast
- Cystic Disease of Breast
- Breast Cystic Disease
- Breast Cystic Diseases
Below are MeSH descriptors whose meaning is more general than "Fibrocystic Breast Disease".
Below are MeSH descriptors whose meaning is more specific than "Fibrocystic Breast Disease".
This graph shows the total number of publications written about "Fibrocystic Breast Disease" by people in this website by year, and whether "Fibrocystic Breast Disease" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Fibrocystic Breast Disease" by people in Profiles.
Cyclooxygenase-2 expression during immortalization and breast cancer progression. Cancer Res. 2008 Jan 15; 68(2):467-75.
AlphaB-crystallin: a novel marker of invasive basal-like and metaplastic breast carcinomas. Ann Diagn Pathol. 2008 Feb; 12(1):33-40.
Multimodality computerized diagnosis of breast lesions using mammography and sonography. Acad Radiol. 2005 Aug; 12(8):970-9.
C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu. Int J Cancer. 2005 Feb 10; 113(4):678-82.
Double immunolabeling with cytokeratin and smooth-muscle actin in confirming early invasive carcinoma of breast. Am J Surg Pathol. 1999 Feb; 23(2):176-81.
Improving breast cancer diagnosis with computer-aided diagnosis. Acad Radiol. 1999 Jan; 6(1):22-33.
Immunohistochemical analysis of estrogen and progesterone receptors in benign breast diseases. Zentralbl Pathol. 1991; 137(3):227-32.
Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors. Cancer Res. 1989 Sep 15; 49(18):5176-9.